WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Bacterial peritonitis requires effective pathogen clearance by macrophages via phagocytosis.
• Oxidized phospholipids (OxPL) are danger-associated molecular patterns (DAMPs) that impair bacterial phagocytosis.
• Understanding OxPL's mechanism is crucial for combating infections and sepsis.

Purpose of the Study:

• To elucidate the molecular mechanism by which OxPL inhibit macrophage phagocytosis.
• To identify key proteins involved in OxPL-mediated suppression of bacterial clearance.
• To evaluate the therapeutic potential of targeting this pathway in vivo and in human samples.

Main Methods:

• In vitro studies exposing peritoneal macrophages to OxPL and E. coli.
• Pharmacological inhibition and gene silencing (WAVE1) in cell-based assays.
• In vivo studies using chimeric Wave1(-/-) mice challenged with E. coli and OxPL.
• Analysis of human peritoneal dialysis fluid from end-stage renal failure patients.

Main Results:

• OxPL exposure altered macrophage actin polymerization, leading to reduced E. coli uptake.
• Protein kinase A (PKA) and the A-kinase anchoring protein (AKAP) WAVE1 were identified as mediators of OxPL effects.
• Wave1(-/-) mice exhibited enhanced survival following bacterial infection and OxPL treatment.
• Endogenous OxPL in patient dialysis fluid inhibited phagocytosis through WAVE1.

Conclusions:

• WAVE1 is a critical effector of OxPL action, inhibiting macrophage phagocytosis.
• Targeting WAVE1 presents a novel therapeutic strategy for severe bacterial infections like peritonitis.
• This research uncovers an important regulatory role for WAVE1 in innate immunity.